Cargando…

Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021

We describe severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG seroprevalence and antigenemia among patients at a medical center in January–March 2021 using residual clinical blood samples. The overall seroprevalences were 17% by infection and 16% by vaccination. Spent or residual samples...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graciaa, Daniel S., Verkerke, Hans P., Guarner, Jeannette, Moldoveanu, Ana Maria, Cheedarla, Narayanaiah, Arthur, Connie M., Maier, Cheryl L., Neish, Andrew, Auld, Sara C., Campbell, Angie, Gandhi, Neel R., Roback, John D., Shah, N. Sarita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Concise Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726492/ https://www.ncbi.nlm.nih.gov/pubmed/36483398 http://dx.doi.org/10.1017/ash.2022.298

Ejemplares similares

371. Estimating SARS-CoV-2 Seroprevalence from Spent Blood Samples, January–March 2021
por: Graciaa, Daniel, et al.
Publicado: (2021)

Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection( )
por: Verkerke, Hans P, et al.
Publicado: (2022)

COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood
por: Govindaraj, Sakthivel, et al.
Publicado: (2023)

Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers
por: Cheedarla, Narayanaiah, et al.
Publicado: (2022)

Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers
por: Cheedarla, Narayanaiah, et al.
Publicado: (2023)

Association of Uninsurance and VA Coverage with the Uptake and Equity of COVID-19 Vaccination: January–March 2021
por: Gaffney, Adam W, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust
por: Grant, Joseph J., et al.
Publicado: (2020)

Low rates of antibiotic use among ambulatory patients with coronavirus disease 2019 (COVID-19)
por: Smith, Alison G.C., et al.
Publicado: (2022)

Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system
por: Saade, Elie A., et al.
Publicado: (2022)

Seasonality of healthcare-associated Stenotrophomonas maltophilia
por: Auld, Dianne B., et al.
Publicado: (2023)

Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure
por: Hunter, Benton R., et al.
Publicado: (2020)

Characteristics of Hydroxychloroquine Dispensing in the United States, January to May 2020
por: Levin, Zachary, et al.
Publicado: (2021)

January-March 2009
Publicado: (2009)

January-March 2008
Publicado: (2008)

January-March 2007
Publicado: (2007)

January-March 1997
Publicado: (1997)

January-March 1998
Publicado: (1998)

January-March 1999
Publicado: (1999)

January-March 2001
Publicado: (2001)

January-March 2002
Publicado: (2002)

January-March 2003
Publicado: (2003)

January-March 2005
Publicado: (2005)

January-March 2006
Publicado: (2006)

January-March 1996
Publicado: (1996)

January-March 2010
Publicado: (2010)

Blood Group A Enhances SARS-CoV-2 Infection
por: Wu, Shang-Chuen, et al.
Publicado: (2022)

Blood Group A Enhances SARS-CoV-2 Infection
por: Wu, Shang-Chuen, et al.
Publicado: (2023)

Rapid response to a coronavirus disease 2019 (COVID-19) outbreak in a psychiatry hospital—Kanazawa City, Japan, March to April 2020
por: Kato, Hirofumi, et al.
Publicado: (2022)

Buprenorphine Dispensing in Pennsylvania During the COVID-19 Pandemic, January to October 2020
por: Chalasani, Rohan, et al.
Publicado: (2021)

Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27–July 14, 2020
por: Wu, Hsiu, et al.
Publicado: (2021)

Glycopyrrolate-Induced Black Hairy Tongue
por: Prabha, Neel, et al.
Publicado: (2020)

Pityriasis Rosea Unilateralis: A Rare Presentation in Two Females
por: Yadav, Anuja, et al.
Publicado: (2020)

Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment
por: Faliti, Caterina E., et al.
Publicado: (2023)

Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection
por: Damhorst, Gregory L, et al.
Publicado: (2023)

PATIENTS WITH ASTHMA OR ATOPIC DERMATITIS TAKING BIOLOGIC THERAPIES HAVE REDUCED SARS-COV-2 VACCINE RESPONSE AT SIX MONTHS
por: RUNNSTROM, MARTIN C, et al.
Publicado: (2022)

Indian Regulatory Update: January-March 2015
por: Suvarnapathaki, Kedar
Publicado: (2015)

Indian Regulatory Update: January – March 2018
por: Bhave, Amita
Publicado: (2018)

CRD editor’s corner archive: January-March
por: Steiner, Michael C
Publicado: (2022)

Granulomatous Facial Dermatoses in a Child: A Case for Diagnosis
por: Dsouza, Myfanwy Joanne, et al.
Publicado: (2021)

Cerebrospinal fluid shunt–associated surgical site infection with three-month versus twelve-month surveillance periods in Canadian hospitals
por: Choi, Kelly B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0jrkgrte4gml9b1mik9iq9mjue